IPCA Laboratories Limited Financial Ratios
IPCALAB · Healthcare · Current price ₹1,908
P/E ratio
42.4x
P/B ratio
6.2x
ROE
14.2%
ROCE
18.5%
Debt / Equity
0.10
Dividend yield
0.3%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 42.4x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 6.2x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 14.2% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 18.5% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.10 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with IPCA Laboratories Limited's latest numbers.
IPCA Laboratories Limited profitability
IPCA Laboratories Limited generates a return on equity of 14.2% and a return on capital employed of 18.5%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.10 and a P/E of 42.4x, IPCA Laboratories Limited is conservatively financed. Our overall business-quality score for the company is 5.9 / 10.
Understand the ratios
More on IPCA Laboratories Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.